BHIC Discloses Ineffective Controls and Material Weaknesses as Nine-Month Loss Hits $565K
BHIC has more than doubled off its 52-week low of $0.52.
Summary
BioScience Health Innovations posted a $564,885 nine-month loss on revenue down 33% to $2.76M, and disclosed ineffective disclosure controls with four material weaknesses, including no independent board or audit committee.
Key Events · Earnings and Guidance · BHIC
-
Nine-Month Swing to $565K Loss
Net loss of $564,885 for the nine months ended September 30, 2026 versus net income of $875,720 a year earlier; revenue fell to $2,757,381 from $4,115,960.
-
Operating Cash Burn of $1.24M
Net cash used in operating activities was $1,244,807, versus $272,874 provided in the prior-year period, leaving $1,691,858 of cash at quarter end.
-
Material Weaknesses Disclosed
Management concluded disclosure controls and procedures were ineffective at September 30, 2026, citing insufficient accounting resources, no segregation of duties, no independent board or audit committee, and no written control documentation.
-
Related-Party Share Issuance for Platform
The company agreed to issue 450,000 restricted shares to Ageless Holdings for a 40% interest in a customer platform with roughly 15,000 active customers, referenced at about $2,025,000 based on the $4.50 Regulation A offering price.
Analysis · BHIC · Technology
The headline number is the swing from $875,720 of nine-month net income a year ago to a $564,885 loss, with revenue down 33% to $2.76M and operating cash burn of $1.24M. The bigger governance problem is buried in Item 4: management concluded disclosure controls were ineffective at September 30, 2026 and flagged four material weaknesses, including no independent board or audit committee and no segregation of duties. That matters because the company is simultaneously pitching a senior-exchange uplisting and issuing shares to a related party, Ageless Holdings, for a 40% stake in a customer platform. Cash of $1.69M and $2.73M of net working capital keep the lights on near term, but the operating loss and the control gaps raise the cost and uncertainty of both the uplisting and any future raise.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BHIC was trading at $5.00 on OTC in the Technology sector, with a market capitalization of approximately $58.8M. The 52-week trading range was $0.52 to $72.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.